about
Stenting versus endarterectomy for treatment of carotid-artery stenosis.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary arteryTreatment of left anterior descending coronary artery disease with sirolimus-eluting stentsQuantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteriesCarotid artery stenting is associated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phaseAntithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyResults of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trialIncidence, timing, and correlates of stent thrombosis with the polymeric paclitaxel drug-eluting stent: a TAXUS II, IV, V, and VI meta-analysis of 3,445 patients followed for up to 3 yearsSafety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy)The truth and consequences of the COURAGE trialTAXUS VI 2-year follow-up: randomized comparison of polymer-based paclitaxel-eluting with bare metal stents for treatment of long, complex lesionsA polymer-based, paclitaxel-eluting stent in patients with coronary artery diseaseAntithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Protected carotid-artery stenting versus endarterectomy in high-risk patientsFrailty assessment in the cardiovascular care of older adultsOne-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study).Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry.Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials.Functional status and quality of life after transcatheter aortic valve replacement: a systematic review.Composite outcomes in coronary bypass surgery versus percutaneous intervention.Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry.Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research ConsortiumDistal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy.Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity.Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.Beta emitter systems and results from clinical trials. state of the art.Prediction of sites of coronary atherosclerosis progression: In vivo profiling of endothelial shear stress, lumen, and outer vessel wall characteristics to predict vascular behavior.Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients.Cutting balloon entrapment during treatment of in-stent restenosis: an unusual complication and its management.Clinical studies assessing transcatheter aortic valve replacement.Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.One-Year Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease.Comparative effectiveness of revascularization strategiesThe cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease).The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (acute coronary syndromes through renal disease) and future directions.Carotid angiographic characteristics in the CREST trial were major contributors to periprocedural stroke and death differences between carotid artery stenting and carotid endarterectomy.Thrombosis and drug-eluting stents: an objective appraisal.Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI).Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients.
P50
Q24619941-02CDF1B4-75BB-4924-B435-A9728A073521Q28206536-9CD3723C-164B-44BB-B25F-F92951835E16Q28208576-6F5CE129-1C1F-4181-87EF-2B3D69DC4DAEQ28211687-308C9EEA-41E5-4CE8-AAB6-D112C4F70F96Q28212375-91245D88-89AA-4019-8F66-CFCD23E9C810Q28213485-408BF9D4-A4E2-4F1B-B520-3497EED46228Q28220325-409F77A6-8AF3-48DA-AD5E-64E0D33F22B5Q28220495-B8EB018D-244B-4ACB-9DFA-A3F226D8171EQ28222362-4210D1D9-5F10-46A3-99BD-26795A619DEAQ28222669-75AD8F94-D5E1-4DCD-B80E-339BF3ED08F1Q28222747-70A39F47-DA02-4B5E-B626-8A6D160D0997Q28238811-C9EC6791-715A-4CF6-A899-A77B21ED1713Q28284905-F585D24C-7AA8-4A11-B330-7D7CF373BDB9Q28286624-1F11D775-056A-4E74-A0A8-3DA84079A19EQ28303050-27BB4ADA-A125-4B4E-B449-49D648188B8DQ30278496-BE93912C-FBCD-4F79-A392-375599D22552Q30577734-9F11589E-C0E5-4A29-88E3-1B1983524C64Q30967015-167489AC-2992-4E6A-A9E4-E9E0058426D9Q31141831-ECA379B0-58D6-448E-BF95-7FA111AAB466Q33688018-52185AF6-ABB2-4018-9523-13925A1CDACEQ33924170-F797968C-5B0B-4127-BD29-BF9BC7EF2B31Q34169161-99CA25AA-7442-486E-BD26-04A9B1185B1BQ34492675-D46AE09D-71B7-4494-BD24-EFC98BF1697EQ35006429-03110816-05F4-45F8-A505-993C88C5E159Q35072469-4046E346-369A-4312-8F07-9E3709042BD2Q35185039-9AA7B77D-BEC9-4917-AD66-DD854F527CC8Q35569134-849F7A1A-3253-44B6-8B4B-8D864672C361Q35575626-7D95A52B-D192-4053-A043-6795FA64A505Q35934997-166F64AB-02CA-4C0F-9032-5C4148167B6BQ36113858-CA23D6BF-49FC-40DE-9D7B-A2198B6AEA96Q36119341-E8A63505-2ABD-44B1-87B0-380174F1D515Q36141199-2414FC1A-7C37-4C68-ABEE-F31EB463D327Q36292364-A6EC08EF-360B-4E08-A2CE-741FB42413A5Q36351313-B6774CDD-534A-4F4A-8B11-A9A4413833C8Q36688070-23E7EABE-2166-4C08-BBC5-BD6BE499DDD9Q36688074-653B48E4-1B11-49FC-A2C8-765E18CAADB8Q36763689-08C2BB29-E365-49BD-BE6E-69450E9C1946Q36872486-A13E571E-DA30-4006-9E39-79101476F4A5Q36909780-9EC2F885-5385-45CB-8B4E-E1C4237228ECQ36976769-330A4D23-B8D3-4D4A-9057-DF525071E293
P50
name
Jeffrey J Popma
@en
type
label
Jeffrey J Popma
@en
prefLabel
Jeffrey J Popma
@en